CC

CIRCUIT CITY STORES, INC.
CC

Overview Fund Activity
Delisted

CC was delisted on the 10th of November, 2008.

Back to rankings
Consumer Discretionary Specialty Retail

Financial journalist opinion

Neutral
Business Wire
6 days ago
Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals.
Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals
Positive
Zacks Investment Research
12 days ago
Chemours Enters Strategic Agreement With SRF to Boost Supply
CC partners with SRF to expand global supply chain, boost operational flexibility and strengthen its high-value product mix.
Chemours Enters Strategic Agreement With SRF to Boost Supply
Neutral
Business Wire
14 days ago
Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026.
Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026
Neutral
Business Wire
19 days ago
Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid.
Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid
Positive
Zacks Investment Research
20 days ago
Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes
CC posts Q2 earnings and sales beat driven by volume and pricing gains, but issues softer sequential guidance.
Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes
Positive
Seeking Alpha
24 days ago
Chemours: Solid Q2 And Legal Progress Are Bullish (Rating Upgrade)
Chemours is showing financial improvement, especially in Opteon refrigerants, despite industry headwinds and a recent dividend cut. The company's legal overhang is easing after a favorable New Jersey PFAS settlement, freeing up future cash flow and reducing uncertainty. Balance sheet leverage remains high, but improving free cash flow in the second half should reduce net debt and support the current dividend.
Chemours: Solid Q2 And Legal Progress Are Bullish (Rating Upgrade)
Positive
The Motley Fool
26 days ago
Chemours (CC) Q2 EPS Jumps 53%
Chemours (CC) Q2 EPS Jumps 53%
Chemours (CC) Q2 EPS Jumps 53%
Neutral
Seeking Alpha
26 days ago
The Chemours Company (CC) Q2 2025 Earnings Call Transcript
The Chemours Company (NYSE:CC ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Brandon Ontjes - Vice President of Investor Relations Denise M. Dignam - President, CEO & Director Shane W.
The Chemours Company (CC) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
27 days ago
Chemours (CC) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Chemours (CC) Reports Q2 Earnings: What Key Metrics Have to Say
Positive
Zacks Investment Research
27 days ago
Chemours (CC) Tops Q2 Earnings and Revenue Estimates
Chemours (CC) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.38 per share a year ago.
Chemours (CC) Tops Q2 Earnings and Revenue Estimates
See News Rankings
Charts implemented using Lightweight Charts™